oregon psilocybin licensing subcommittee

Oregon Psilocybin: Licensing Subcommittee Update

Time for another Oregon psilocybin licensing update. In this post we will explain what the Licensing Subcommittee covered in its recent meeting on March 3, 2022. Licensing Subcommittee schedule and timelines The Licensing Subcommittee meets every month to develop licensing requirements for psilocybin businesses and professionals. So far, it has developed recommendations regarding informed consent

oregon psilocybin webinar

FREE Oregon Psilocybin Webinar: OHA and Harris Bricken

Watch HERE! Please join Harris Bricken lawyers Mason Marks and Vince Sliwoski as they team up with Angela Allbee of the Oregon Health Authority (OHA) for a lunch hour webinar on April 7. Angela, Mason and Vince will discuss updates on OHA rulemaking, policy and licensing, as well as business issues for Oregon’s imminent psilocybin

rico racketeering psychedelics

RICO and Psychedelics

RICO (or the federal Racketeer Influenced and Corrupt Organizations Act) has been a thorn in the foot for cannabis companies since, well, the dawn of cannabis companies. RICO will be just as annoying for psychedelics companies. Today I will explain what RICO is and why RICO and psychedelics will have a rocky relationship. What is

oregon psilocybin webinar

FREE Oregon Psilocybin Webinar: OHA and Harris Bricken

Watch HERE! Please join Harris Bricken lawyers Mason Marks and Vince Sliwoski as they team up with Angela Allbee of the Oregon Health Authority (OHA) for a lunch hour webinar on April 7. Angela, Mason and Vince will discuss updates on OHA rulemaking, policy and licensing, as well as business issues for Oregon’s imminent psilocybin

ketamine clinic red flag

Ketamine Clinic Red Flags and Warnings

Ketamine clinic providers engaged in the off label application of ketamine for patient treatment are nothing new in U.S. healthcare. What is relatively new is that many “psychedelics” companies are trying to infiltrate the ketamine clinic scene. These companies hope to gain a foothold, then expand into a fuller suite of psychedelic treatment services once

oregon psilocybin facilitator recommendation

Oregon Psilocybin: Facilitator Exam Recommendations to Date

In this post, we’ll discuss Oregon psilocybin facilitator exam recommendations to date under Measure 109. Competency exams are common for professions such as therapists, public school teachers and nurses. For instance, every state has a Nurse Practice Act to protect public safety by requiring nurses to pass a certification exam prior to practicing as a

dea religious exemption psychedelics

How DEA Denies Religious Exemption Petitions: Part 2

In part 1 of this series, I examined how the DEA denied Soul Quest’s petition for a religious exemption to the Controlled Substances Act (CSA). As I noted, DEA rarely, if ever, responds to or grants petitions for religious exemptions to the CSA. Soul Quest’s denial was one of the few cases where we actually

oregon psilocybin reassuring touch

Oregon Psilocybin: Reassuring Touch

When a person ingests psilocybin, in any form, the effects can be unpredictable. Some people will feel no different than normal. Others find themselves in a state of emotional reflection, ranging from light to deep introspection. Yet some experience moments of fear, anxiety, or reliving past trauma. How may a facilitator assist a person experiencing

DEA Denies Religious Exemption

How DEA Denies Religious Exemption Petitions: Part 1

We’ve discussed at length the DEA’s process for seeking religious exemptions to the Controlled Substances Act (CSA). You can read about that in my posts linked at the bottom of this one. Critics of the religious exemption petition process claim that the DEA rarely, if ever, responds to petitions. They also complain that they are

Exception to DEA Ketamine Registration

Exception to DEA Ketamine Registration

Ketamine is a Schedule III drug under the federal Controlled Substances Act (CSA). Physicians who dispense or administer it therefore must comply with a host of federal and state laws and regulations. This includes registering with the DEA at each location where the physician administers ketamine. But what about physicians who travel to a patient’s